Aimei Health Technology Co., Ltd
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AFJK research report →
Companywww.aimeihealth.com
Aimei Health Technology Co. , Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.
- CEO
- Junheng Xie
- IPO
- 2024
- Employees
- 2
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $287.84M
- P/E
- 179.57
- P/S
- 0.00
- P/B
- 23.67
- EV/EBITDA
- -346.83
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 3.19%
- ROIC
- -7.77%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $1.06M · -58.47%
- EPS
- $0.17 · -39.29%
- Op Income
- $-835,759
- FCF YoY
- 15.94%
Performance & Tape
- 52W High
- $130.37
- 52W Low
- $6.75
- 50D MA
- $37.42
- 200D MA
- $29.00
- Beta
- 0.46
- Avg Volume
- 18.51K
Get TickerSpark's AI analysis on AFJK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 11, 25 | MIZUHO SECURITIES USA LLC | sell | 150,000 |
| Feb 10, 25 | MIZUHO SECURITIES USA LLC | other | 0 |
Our AFJK Coverage
We haven't published any research on AFJK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate AFJK Report →